CareMetx (owned by The Vistria Group) acquired VirMedica (owned by Petra Capital Partners) September 2018


CareMetx, a technology-enabled hub services and provider for pharmaceutical and biotechnology manufacturers, announced its acquisition of VirMedica on September 6, 2018.

VirMedica is the industry leader in providing proprietary e-access technology solutions designed to expedite patient access by simplifying, automating, and ultimately accelerating the processes required for patients when accessing specialty therapies.


“With VirMedica’s market-leading transactions, we have an opportunity to leverage technology to transform the patient access landscape,” said Mark Hansan, President & CEO of CareMetx. “We look forward to further automating patient onboarding processes, providing efficiencies for our clients, and improving speed to therapy for all patients.”

The acquisition creates an opportunity to leverage VirMedica’s electronic benefits verification technology and serve as the “front-end” to patient access ecosystems.

Crosstree’s Role

Crosstree Capital Partners served as exclusive financial advisor to VirMedica.


Pharma Services
Healthcare Technology


Merger and Acquisition

Deal Tags

Clinical Trials
Pharma Development
Patient and Site Engagement
Pharma Commerizational